Teva Pharmaceuticals has reached a $54 million settlement in a lawsuit filed by two whistleblowers concerning alleged violations of the False Claims Act and the Anti-Kickback Statute. Teva’s compliance argument did not hold water, the judge found.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...